1-4 of 4
Hyam Levitsky, MD
Close
Sort by
Journal Articles

A Randomized Phase II Trial of Interferon (IFN)/GM-CSF Versus K562/GM-CSF Vaccination in Chronic Phase CML Patients on Frontline Tyrosine Kinase Inhibitor (TKI) Therapy: Potential of IFN to Enhance Molecular Remissions

Jonathan Allen Webster, MD, Anna Ferguson, BSN, RN, Christopher Gocke, MD, Richard J Jones, MD, Hyam Levitsky, MD, B. Douglas Smith, MD
Journal: Blood
Blood (2016) 128 (22): 3088.
https://doi.org/10.1182/blood.V128.22.3088.3088
Published: 2016
Journal Articles

Tumor Antigen Vaccination of Donors to Augment Graft-Versus-Tumor Effects after Allogeneic Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide

Han-Hsuan Fu, PhD, Jie Wang, MD, Jie Fu, MS, Richard J Jones, MD, Hyam Levitsky, MD, Ephraim J. Fuchs, MD
Journal: Blood
Blood (2016) 128 (22): 499.
https://doi.org/10.1182/blood.V128.22.499.499
Published: 2016
Journal Articles

Identification of New Alloantigen-Reactive CD8 + Cytotoxic and Suppressor T Cell Subpopulations.

Osnat Bohana-Kashtan, PhD, Hyam Levitsky, MD, Curt I. Civin, MD
Journal: Blood
Blood (2007) 110 (11): 3229.
https://doi.org/10.1182/blood.V110.11.3229.3229
Published: 2007
Journal Articles

Characterization of Vaccine Site and Cellular Infiltrate in Subjects with Chronic Myeloid Leukemia (CML) Receiving K562/GM-CSF Vaccination in Combination with Imatinib Mesylate with or without Topical Imiquimod.

Christina Y. Chia, MD, B. Douglas Smith, MD, Yvette Kasamon, MD, Carole B. Miller, MD, Mary E. Brummet, MS, Lora Bankova, MD, Jeanne Kowalski, PhD, Barbara Biedrzycki, MSN, Kristen Hege, Lisa A. Beck, MD, Hyam Levitsky, MD
Journal: Blood
Blood (2005) 106 (11): 2399.
https://doi.org/10.1182/blood.V106.11.2399.2399
Published: 2005